{"id":33619,"date":"2024-08-05T14:10:48","date_gmt":"2024-08-05T12:10:48","guid":{"rendered":"https:\/\/www.incliva.es\/services\/researcher-services\/scientific-management\/international\/featured-projects\/hypermarker\/"},"modified":"2024-08-05T14:22:48","modified_gmt":"2024-08-05T12:22:48","slug":"hypermarker","status":"publish","type":"page","link":"https:\/\/www.incliva.es\/en\/services\/researcher-services\/scientific-management\/international\/featured-projects\/hypermarker\/","title":{"rendered":"HYPERMARKER"},"content":{"rendered":"<div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;border-width: 0px 0px 0px 0px;border-color:#e2e2e2;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_2_3 2_3 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div style=\"text-align:center;\"><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none\"><img width=\"280\" height=\"243\" title=\"Logo Hypermarker\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2023\/05\/Logo-Hypermarker.jpg\" class=\"img-responsive wp-image-21348\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2023\/05\/Logo-Hypermarker-200x174.jpg 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2023\/05\/Logo-Hypermarker.jpg 280w\" sizes=\"(max-width: 640px) 100vw, 280px\" \/><\/span><\/div><style type=\"text\/css\">@media only screen and (max-width:1532px) {.fusion-title.fusion-title-1{margin-top:10px!important;margin-bottom:15px!important;}}@media only screen and (max-width:640px) {.fusion-title.fusion-title-1{margin-top:10px!important;margin-bottom:10px!important;}}<\/style><div class=\"fusion-title title fusion-title-1 fusion-title-text fusion-title-size-one\" style=\"margin-top:10px;margin-bottom:15px;\"><div class=\"title-sep-container title-sep-container-left fusion-no-large-visibility fusion-no-medium-visibility fusion-no-small-visibility\"><div class=\"title-sep sep-single sep-solid\" style=\"border-color:#3d44ac;\"><\/div><\/div><h1 class=\"title-heading-left\" style=\"margin:0;\"><\/h1><div class=\"title-sep-container title-sep-container-right\"><div class=\"title-sep sep-single sep-solid\" style=\"border-color:#3d44ac;\"><\/div><\/div><\/div><div class=\"fusion-text fusion-text-1\" style=\"transform:translate3d(0,0,0);\"><h6>Personalised pharmacometabolomic optimisation of treatment for hypertension<\/h6>\n<\/div><div class=\"fusion-text fusion-text-2\" style=\"transform:translate3d(0,0,0);\"><p>La\u00a0hipertensi\u00f3n, o tensi\u00f3n arterial alta, es una afecci\u00f3n m\u00e9dica grave y el\u00a0principal factor causante de enfermedades circulatorias. Sigue siendo una de las principales causas de mortalidad y morbilidad en todo el mundo, con una elevada carga social y econ\u00f3mica para los pacientes y los sistemas sanitarios. Aunque existen muchos tratamientos para la hipertensi\u00f3n, el control de la presi\u00f3n arterial sigue siendo deficiente en la mayor\u00eda de los pa\u00edses, con consecuencias evitables como infartos de miocardio, accidentes cerebrovasculares, enfermedades renales y demencia.<\/p>\n<p><span data-contrast=\"auto\">El objetivo de Hypermarker es encontrar soluciones innovadoras para el tratamiento de la hipertensi\u00f3n mediante la combinaci\u00f3n de investigaciones cient\u00edficas avanzadas y un enfoque centrado en el paciente. Para el desarrollo del proyecto se emplear\u00e1n enfoques de inteligencia artificial y m\u00e9todos de aprendizaje profundo para integrar esta informaci\u00f3n con factores cl\u00ednicos y determinar el tratamiento \u00f3ptimo para cada paciente. El proyecto se desarrolla en cuatro fases, cada una con una duraci\u00f3n aproximada de un a\u00f1o.<\/span><\/p>\n<p><span data-contrast=\"auto\"> La primera fase consiste en la recopilaci\u00f3n de datos cl\u00ednicos y muestras de sangre para an\u00e1lisis farmacometabol\u00f3micos en Leiden.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><span data-contrast=\"auto\">En la segunda fase, la Universidad de Birmingham crear\u00e1 un modelo predictivo basado en los resultados de estos an\u00e1lisis. Este modelo se validar\u00e1 en la tercera fase mediante un ensayo cl\u00ednico para comprobar su aplicabilidad en la pr\u00e1ctica cl\u00ednica. Finalmente, en la cuarta fase, se dise\u00f1ar\u00e1n una herramienta de decisi\u00f3n cl\u00ednica y una herramienta de diagn\u00f3stico complementaria, con potencial para ser comercializadas.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335551550&quot;:6,&quot;335551620&quot;:6,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><strong>Consorcio<\/strong><br \/>\nAdem\u00e1s de INCLIVA, en HYPERMARKER participan el Centro M\u00e9dico Universitario UCM, de Utrecht (Pa\u00edses Bajos); la Universidad de Birmingham y University Hospitals Birmingham NHS Foundation Trust (Reino Unido); la Universidad de Leiden (Pa\u00edses Bajos); el Centro M\u00e9dico Hamburg-Eppendorf (Alemania); la Universidad de Utrecht (Pa\u00edses Bajos); London School of Economics (Reino Unido); la empresa Medicine Men (Pa\u00edses Bajos); la empresa Euretos (Pa\u00edses Bajos); Red Europea del Coraz\u00f3n (B\u00e9lgica); Roche Diagnostics (Pa\u00edses Bajos); y Steinbeisser Project Management UG (Alemania).<\/p>\n<p><strong>El papel de INCLIVA<\/strong><br \/>\nINCLIVA realizar\u00e1 un\u00a0seguimiento de pacientes hipertensos de dif\u00edcil control\u00a0en el que se\u00a0les facilitar\u00e1n instrumentos para conseguir la normalizaci\u00f3n de la presi\u00f3n arterial y se valorar\u00e1n par\u00e1metros de metabol\u00f3mica\u00a0con el fin de\u00a0optimizar el tratamiento a recibir para obtener la respuesta terap\u00e9utica adecuada y reducir el riesgo cardiovascular y renal.<\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;width:100%;\"><div class=\"fusion-separator-border sep-single\" style=\"border-color:#9da0d2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-3\" style=\"transform:translate3d(0,0,0);\"><p><strong>Financiaci\u00f3n<\/strong><\/p>\n<p><img class=\"size-full wp-image-17762 alignleft\" src=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2023\/02\/cofinanciado-ue.jpg\" alt=\"\" width=\"300\" height=\"63\" srcset=\"https:\/\/www.incliva.es\/wp-content\/uploads\/2023\/02\/cofinanciado-ue-200x42.jpg 200w, https:\/\/www.incliva.es\/wp-content\/uploads\/2023\/02\/cofinanciado-ue.jpg 300w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>This project was funded by the European Union under Grant Agreement number 101095480. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.<\/p>\n<\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-0{width:66.666666666667% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-0 > .fusion-column-wrapper {padding-top : 0px !important;padding-right : 0px !important;margin-right : 2.88%;padding-bottom : 0px !important;padding-left : 0px !important;margin-left : 2.88%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-0{width:66.666666666667% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 2.88%;margin-left : 2.88%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-0{width:100% !important;}.fusion-builder-column-0 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_3 1_3 fusion-flex-column\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f9f9f9;border-width: 0 0 0 2px;border-color:#9DA0D2;border-style:solid;box-shadow:0px 0px ;;padding: 4% 4% 4% 4%;\"><div class=\"fusion-text fusion-text-4\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">PROGRAMA<\/h5>\n<p style=\"text-align: center;\">Horizon Health<\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:10px;margin-bottom:10px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#9DA0D2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-5\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">INVESTIGADOR PRINCIPAL<\/h5>\n<p style=\"text-align: center;\">Prof. Dr. Josep Red\u00f3n<\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:10px;margin-bottom:10px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#9DA0D2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-6\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">FUNCI\u00d3N<\/h5>\n<p style=\"text-align: center;\">Socios<\/p>\n<\/div><div class=\"fusion-text fusion-text-7\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">FINANCIACI\u00d3N<\/h5>\n<p style=\"text-align: center;\">400.000 \u20ac<\/p>\n<\/div><div class=\"fusion-text fusion-text-8\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">INICIO\/FIN<\/h5>\n<p style=\"text-align: center;\">2023-2026<\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:10px;margin-bottom:10px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#9DA0D2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-9\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">WEB<\/h5>\n<p style=\"text-align: center;\"><a href=\"https:\/\/www.hypermarker.eu\/\" target=\"_blank\" rel=\"noopener\">www.hypermarker.eu<\/a><\/p>\n<\/div><div class=\"fusion-text fusion-text-10\" style=\"transform:translate3d(0,0,0);\"><h5 style=\"text-align: center;\">REDES SOCIALES<\/h5>\n<\/div><div class=\"fusion-social-links\" style=\"text-align:center\"><div class=\"fusion-social-networks\"><div class=\"fusion-social-networks-wrapper\"><a class=\"fusion-social-network-icon fusion-tooltip fusion-twitter fusion-icon-twitter\" style=\"color:#9ea0a4;font-size:16px;\" data-placement=\"top\" data-title=\"Twitter\" data-toggle=\"tooltip\" title=\"Twitter\" aria-label=\"twitter\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/twitter.com\/hypermarker\"><\/a><a class=\"fusion-social-network-icon fusion-tooltip fusion-linkedin fusion-icon-linkedin\" style=\"color:#9ea0a4;font-size:16px;\" data-placement=\"top\" data-title=\"LinkedIn\" data-toggle=\"tooltip\" title=\"LinkedIn\" aria-label=\"linkedin\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/www.linkedin.com\/company\/hypermarker\"><\/a><a class=\"fusion-social-network-icon fusion-tooltip fusion-youtube fusion-icon-youtube\" style=\"color:#9ea0a4;font-size:16px;\" data-placement=\"top\" data-title=\"YouTube\" data-toggle=\"tooltip\" title=\"YouTube\" aria-label=\"youtube\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/www.youtube.com\/@Hypermarker-project\"><\/a><\/div><\/div><\/div><\/div><\/div><style type=\"text\/css\">.fusion-body .fusion-builder-column-1{width:33.333333333333% !important;margin-top : 0px;margin-bottom : 20px;}.fusion-builder-column-1 > .fusion-column-wrapper {padding-top : 4% !important;padding-right : 4% !important;margin-right : 5.76%;padding-bottom : 4% !important;padding-left : 4% !important;margin-left : 5.76%;}@media only screen and (max-width:1532px) {.fusion-body .fusion-builder-column-1{width:33.333333333333% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 5.76%;margin-left : 5.76%;}}@media only screen and (max-width:640px) {.fusion-body .fusion-builder-column-1{width:100% !important;order : 0;}.fusion-builder-column-1 > .fusion-column-wrapper {margin-right : 1.92%;margin-left : 1.92%;}}<\/style><\/div><style type=\"text\/css\">.fusion-body .fusion-flex-container.fusion-builder-row-1{ padding-top : 0px;margin-top : 0px;padding-right : 0px;padding-bottom : 0px;margin-bottom : 0px;padding-left : 0px;}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":10,"featured_media":0,"parent":9839,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/33619"}],"collection":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/comments?post=33619"}],"version-history":[{"count":2,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/33619\/revisions"}],"predecessor-version":[{"id":33628,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/33619\/revisions\/33628"}],"up":[{"embeddable":true,"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/pages\/9839"}],"wp:attachment":[{"href":"https:\/\/www.incliva.es\/en\/wp-json\/wp\/v2\/media?parent=33619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}